Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer

BACKGROUND: Most prognostic signatures for colorectal cancer (CRC) are developed to predict overall survival (OS). Gene signatures predicting recurrence-free survival (RFS) are rarely reported, and postoperative recurrence results in a poor outcome. Thus, we aim to construct a robust, individualized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Leqi, Yu, Yue, Wen, Rongbo, Zheng, Kuo, Jiang, Siyuan, Zhu, Xiaoming, Sui, Jinke, Gong, Haifeng, Lou, Zheng, Hao, Liqiang, Yu, Guanyu, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127348/
https://www.ncbi.nlm.nih.gov/pubmed/35619909
http://dx.doi.org/10.3389/fonc.2022.863094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127348/
https://www.ncbi.nlm.nih.gov/pubmed/35619909
http://dx.doi.org/10.3389/fonc.2022.863094

Ejemplares similares